Cartesian Therapeutics (RNAC) Shares Issued (2016 - 2025)
Historic Shares Issued for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $5000.0.
- Cartesian Therapeutics' Shares Issued fell 9999.59% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $273000.0, marking a year-over-year decrease of 9978.06%. This contributed to the annual value of $124.4 million for FY2024, which is 5376926.41% up from last year.
- According to the latest figures from Q3 2025, Cartesian Therapeutics' Shares Issued is $5000.0, which was down 9999.59% from $85000.0 recorded in Q2 2025.
- Cartesian Therapeutics' Shares Issued's 5-year high stood at $121.6 million during Q3 2024, with a 5-year trough of -$20.3 million in Q2 2021.
- Moreover, its 5-year median value for Shares Issued was $115500.0 (2021), whereas its average is $11.6 million.
- Its Shares Issued has fluctuated over the past 5 years, first plummeted by 214006.02% in 2021, then soared by 14814512.2% in 2024.
- Quarter analysis of 5 years shows Cartesian Therapeutics' Shares Issued stood at $104000.0 in 2021, then plummeted by 129.81% to -$31000.0 in 2022, then soared by 364.52% to $82000.0 in 2023, then surged by 148145.12% to $121.6 million in 2024, then plummeted by 100.0% to $5000.0 in 2025.
- Its last three reported values are $5000.0 in Q3 2025, $85000.0 for Q2 2025, and $183000.0 during Q1 2025.